Feature Article

ACIP Updates Recommendations for US Adult Immunization Schedule


The ACIP and CDC have approved and released 2019 recommendations for the adult immunization schedule in the US.

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News


Ready-to-Use, Room Temp Stable, Premixed Vancomycin Injection Gets FDA Approval

By February 21, 2019

Xellia announced that the Food and Drug Administration (FDA) has approved its Premixed Vancomycin Injection in a Ready-to-Use bag.


Risk for MRSA Reduced With Postdischarge Decolonization

February 20, 2019

For patients colonized with methicillin-resistant Staphylococcus aureus (MRSA), postdischarge MRSA decolonization is associated with a reduced risk for infection.


FDA Issues Complete Response Letter Rejecting Iclaprim Approval for ABSSSI

By February 19, 2019

The NDA included data from the Phase 3 REVIVE-1 and REVIVE-2 trials.


Dermatology, Infectious Disease Collaboration May Optimize Detection of Sexually Transmitted Infections

By February 19, 2019

Over the study period, significant increases in the number of screening tests, as well as the ratio between the tests and hospital admissions, was observed.


Progress Made in Developing New Antibacterial Agents

February 15, 2019

Although there has been progress in the development of new antibacterial drugs, most of the recently approved agents have been modifications of existing chemical classes of antibiotics.


Nuzyra Now Available in IV, Oral Forms for CABP, ABSSSI

By February 14, 2019

Nuzyra, an aminomethylcycline (related to tetracycline antibiotics), is designed to overcome tetracycline resistance and has broad-spectrum activity against Gram-positive, Gram-negative and atypical bacteria, and other drug-resistant strains.


Trends in US Herpes Zoster Hospitalizations From 2001 to 2015

By Zahra Masoud February 14, 2019

The 2007 and 2008 shingles and varicella vaccination recommendations may have contributed to the declining herpes zoster hospitalization rates in some groups.


Omadacycline Noninferior to Moxifloxacin in CABP Study, Linezolid in ABSSSI Study

February 13, 2019

Omadacycline is noninferior to moxifloxacin for community-acquired bacterial pneumonia and noninferior to linezolid for acute bacterial skin infections.


CDC Examines Safety of Recombinant Zoster Vaccine

February 06, 2019

During the first eight months of recombinant zoster vaccine (RZV) use, there were reports of 4,381 adverse events, 3 percent of which were serious.


Washington State Declares Health Emergency as Measles Spreads

January 30, 2019

A statewide public health emergency was declared in Washington after a measles outbreak near Portland, Oregon, reached 31 cases on Friday.

Sign up for Newsletters